Mizuki Yaginuma
Overview
Explore the profile of Mizuki Yaginuma including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
16
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Furuichi M, Ohnishi T, Yaginuma M, Yamada Y, Hoshino K, Nakayama T, et al.
Vaccine
. 2024 Nov;
43(Pt 1):126527.
PMID: 39547018
Background: A recent conditional recommendation suggests considering live-attenuated vaccines for solid organ transplant recipients, yet the conditions of their safe and effective administration remain unclear. Methods: This prospective study was...
2.
Furuichi M, Kawaguchi T, Pust M, Yasuma-Mitobe K, Plichta D, Hasegawa N, et al.
Nature
. 2024 Sep;
633(8031):878-886.
PMID: 39294375
Persistent colonization and outgrowth of potentially pathogenic organisms in the intestine can result from long-term antibiotic use or inflammatory conditions, and may perpetuate dysregulated immunity and tissue damage. Gram-negative Enterobacteriaceae...
3.
Shinjoh M, Yaginuma M, Yamaguchi Y, Tamura K, Furuichi M, Tsumura Y, et al.
Vaccine
. 2024 Aug;
42(23):126241.
PMID: 39178768
Background: The annual administration of the influenza vaccine is the most effective method for preventing influenza. We have evaluated the effectiveness of the inactivated influenza vaccine in children aged 6 ...
4.
Shinjoh M, Furuichi M, Yamada Y, Ohnishi T, Yaginuma M, Hoshino K, et al.
Am J Transplant
. 2024 Jul;
25(1):189-197.
PMID: 39009348
Recently, live-attenuated measles, rubella, varicella, and mumps vaccines have been administered to carefully selected post-liver transplant patients. Although attention has been focused on post-vaccination antibody titers and adverse events, the...
5.
Honda K, Furuichi M, Kawaguchi T, Pust M, Yasuma-Mitobe K, Plichta D, et al.
Res Sq
. 2023 Nov;
PMID: 37961431
Persistent colonization and outgrowth of pathogenic organisms in the intestine may occur due to long-term antibiotic usage or inflammatory conditions, which perpetuate dysregulated immunity and tissue damage. Gram-negative gut pathobionts...
6.
Oikawa H, Morooka Y, Furuichi M, Shinjoh M, Nozaki S, Nishi E, et al.
J Infect Chemother
. 2023 Oct;
30(3):194-200.
PMID: 37805098
Introduction: Studies investigating the role of urinary tract abnormalities in the development of catheter-associated urinary tract infections (CAUTI) in young children are limited. Thus, in the present study, we aimed...
7.
Shioji Y, Yaginuma M, Ota M, Inoguchi T, Furuichi M, Shinjoh M, et al.
Pediatr Int
. 2023 Sep;
65(1):e15607.
PMID: 37674296
No abstract available.
8.
Ishiwada N, Shinjoh M, Kusama Y, Arakawa H, Ohishi T, Saitoh A, et al.
Pediatr Infect Dis J
. 2023 Aug;
42(10):e369-e376.
PMID: 37566891
The members of the Japanese Society for Pediatric Infectious Diseases and the Japanese Society of Pediatric Pulmonology have developed Guidelines for the Management of Respiratory Infectious Diseases in Children with...
9.
Kawata K, Shima H, Shinjoh M, Yamazaki F, Kurosawa T, Yaginuma M, et al.
Cancer Rep (Hoboken)
. 2023 Aug;
6(10):e1885.
PMID: 37563749
Background: CD19-targeted chimeric antigen receptor (CAR)-T cell therapy involves administration of patient-derived T cells that target B cells, resulting in B-cell depletion and aplasia. In immunity against Pneumocystis jirovecii (Pj),...
10.
Shinjoh M, Furuichi M, Tsuzuki S, Iqbal A, Fukushima N, Soen S, et al.
Vaccine
. 2023 Jul;
41(33):4777-4781.
PMID: 37419851
We have analyzed the inactivated vaccine effectiveness (VE)for preventing influenza hospitalization by test-negative design in the 2022/23 season. This is the first season of co-circulation of influenza and COVID-19, and...